Form 4: Phathom Pharmaceuticals Officer Sells Shares for Tax

Phathom Pharmaceuticals' Principal Accounting Officer, Robert Charles Breedlove, sold 461 shares of common stock to cover tax withholding obligations.

Summary

• Robert Charles Breedlove, Principal Accounting Officer of Phathom Pharmaceuticals, Inc. (PHAT), reported a transaction on September 5, 2025.
• The transaction involved the sale of 461 shares of common stock at a price of $12.09 per share.
• The purpose of this sale was to satisfy tax withholding obligations upon the settlement of restricted stock units.
• Following this transaction, Mr. Breedlove directly beneficially owns 47,931 shares of common stock.
• Additionally, Mr. Breedlove indirectly beneficially owns 6,945.4 shares of common stock through a 401(k) plan.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary sale of shares by an officer to cover tax obligations, which is a common occurrence and generally neutral in sentiment regarding the company's prospects.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing (Form 4) and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual's stock activity rather than company-wide strategic or operational updates.

Stakeholder Impact

• Shareholders: This is a routine, non-discretionary transaction by an officer to cover tax obligations, which typically has minimal impact on shareholder perception or company valuation.

Key Dates

Keywords

Phathom Pharmaceuticals, PHAT, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Officer Transaction